These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 7625886)
1. Effect of Y-25130, a selective 5-hydroxytryptamine3 receptor antagonist, on gastric emptying in mice. Haga K; Asano K; Inaba K; Morimoto Y; Setoguchi M Arch Int Pharmacodyn Ther; 1994; 328(3):344-55. PubMed ID: 7625886 [TBL] [Abstract][Full Text] [Related]
2. Relationship of serotonin-3 receptor antagonist activity to gastric emptying and motor-stimulating actions of prokinetic drugs in dogs. Gullikson GW; Loeffler RF; Viriña MA J Pharmacol Exp Ther; 1991 Jul; 258(1):103-10. PubMed ID: 2072288 [TBL] [Abstract][Full Text] [Related]
3. The effects of orally administered Y-25130, a selective serotonin3-receptor antagonist, on chemotherapeutic agent-induced emesis. Haga K; Inaba K; Shoji H; Morimoto Y; Fukuda T; Setoguchi M Jpn J Pharmacol; 1993 Nov; 63(3):377-83. PubMed ID: 8107329 [TBL] [Abstract][Full Text] [Related]
4. Improvement of cisplatin-induced emesis and delayed gastric emptying by KB-R6933, a novel 5-HT3 receptor antagonist. Ozaki A; Sukamoto T Gen Pharmacol; 1999 Sep; 33(3):283-8. PubMed ID: 10480662 [TBL] [Abstract][Full Text] [Related]
5. Gastroprokinetic properties of the benzimidazolone derivative BIMU 1, an agonist at 5-hydroxytryptamine4 and antagonist at 5-hydroxytryptamine3 receptors. Rizzi CA; Sagrada A; Schiavone A; Schiantarelli P; Cesana R; Schiavi GB; Ladinsky H; Donetti A Naunyn Schmiedebergs Arch Pharmacol; 1994 Apr; 349(4):338-45. PubMed ID: 8058105 [TBL] [Abstract][Full Text] [Related]
6. [Effect of Y-25130 on gastric motility in anesthetized rats]. Odani N; Haga K; Setoguchi M Nihon Yakurigaku Zasshi; 1993 Jan; 101(1):17-26. PubMed ID: 8444378 [TBL] [Abstract][Full Text] [Related]
7. 5-Hydroxytryptamine3 receptor and regulation of gastric emptying in rats. Ito C; Isobe Y; Tsuchida K; Higuchi S Arch Int Pharmacodyn Ther; 1996; 331(2):203-18. PubMed ID: 8937630 [TBL] [Abstract][Full Text] [Related]
8. RS 42358-197, a novel and potent 5-HT3 receptor antagonist, in vitro and in vivo. Eglen RM; Lee CH; Smith WL; Johnson LG; Whiting RL; Hegde SS J Pharmacol Exp Ther; 1993 Aug; 266(2):535-43. PubMed ID: 8355189 [TBL] [Abstract][Full Text] [Related]
9. [Inhibition by Y-25130 of the von Bezold-Jarisch effect evoked by 5-HT or 2-methyl-5-HT in anesthetized rats]. Inaba K; Morimoto Y; Fukuda T; Setoguchi M Nihon Yakurigaku Zasshi; 1991 Oct; 98(4):293-9. PubMed ID: 1802816 [TBL] [Abstract][Full Text] [Related]
10. General pharmacology of the four gastrointestinal motility stimulants bethanechol, metoclopramide, trimebutine, and cisapride. Megens AA; Awouters FH; Niemegeers CJ Arzneimittelforschung; 1991 Jun; 41(6):631-4. PubMed ID: 1930352 [TBL] [Abstract][Full Text] [Related]
11. Effects of gastroprokinetic agents on gastroparesis in streptozotocin-induced diabetic rats. Yamano M; Kamato T; Nagakura Y; Miyata K Naunyn Schmiedebergs Arch Pharmacol; 1997 Jul; 356(1):145-50. PubMed ID: 9228202 [TBL] [Abstract][Full Text] [Related]
12. Cisapride vs metoclopramide. An acute study in diabetic gastroparesis. McHugh S; Lico S; Diamant NE Dig Dis Sci; 1992 Jul; 37(7):997-1001. PubMed ID: 1618070 [TBL] [Abstract][Full Text] [Related]
13. Comparison of potencies of 5-HT3 receptor antagonists at inhibiting aversive behavior to illumination and the von Bezold-Jarisch reflex in the mouse. Eglen RM; Lee CH; Khabbaz M; Fontana DJ; Daniels S; Kilfoil T; Wong EH Neuropharmacology; 1994 Feb; 33(2):227-34. PubMed ID: 8035908 [TBL] [Abstract][Full Text] [Related]
15. Effect of serotonin (5-HT)3-receptor antagonists YM060, YM114 (KAE-393), ondansetron and granisetron on 5-HT4 receptors and gastric emptying in rodents. Miyata K; Yamano M; Kamato T; Akuzawa S Jpn J Pharmacol; 1995 Nov; 69(3):205-14. PubMed ID: 8699628 [TBL] [Abstract][Full Text] [Related]
16. RG 12915: a potent 5-hydroxytryptamine-3 antagonist that is an orally effective inhibitor of cytotoxic drug-induced emesis in the ferret and dog. Fitzpatrick LR; Lambert RM; Pendley CE; Martin GE; Bostwick JS; Gessner GW; Airey JE; Youssefyeh RD; Pendleton RG; Decktor DL J Pharmacol Exp Ther; 1990 Aug; 254(2):450-5. PubMed ID: 2166791 [TBL] [Abstract][Full Text] [Related]
17. Contractile mechanisms of action of gastroprokinetic agents: cisapride, metoclopramide, and domperidone. Orihata M; Sarna SK Am J Physiol; 1994 Apr; 266(4 Pt 1):G665-76. PubMed ID: 8179003 [TBL] [Abstract][Full Text] [Related]
18. LY277359 maleate: a potent and selective 5-HT3 receptor antagonist without gastroprokinetic activity. Cohen ML; Bloomquist W; Gidda JS; Lacefield W J Pharmacol Exp Ther; 1990 Jul; 254(1):350-5. PubMed ID: 2366187 [TBL] [Abstract][Full Text] [Related]
19. Serotonin (5-HT)3-receptor antagonism of 4,5,6,7-tetrahydrobenzimidazole derivatives against 5-HT-induced bradycardia in anesthetized rats. Yamano M; Kamato T; Nishida A; Ito H; Yuki H; Tsutsumi R; Honda K; Miyata K Jpn J Pharmacol; 1994 Jul; 65(3):241-8. PubMed ID: 7799524 [TBL] [Abstract][Full Text] [Related]
20. Species difference in the 5-hydroxytryptamine3 receptor associated with the von Bezold-Jarisch reflex. Yamano M; Ito H; Kamato T; Miyata K Arch Int Pharmacodyn Ther; 1995; 330(2):177-89. PubMed ID: 8861711 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]